LONDON, July 26, 2024 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its second quarter 2024 financial results and operational highlights before open of US markets on Thursday, August 8, 2024.
Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.
A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.
Contact:
Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com
Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com
Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com
The EUR/USD outlook suggests further weakness for the dollar. The dollar collapsed as Trump continued…
Media invited to attend the first Vancouver stop on New Economy Canada’s “Getting things built”…
RICHMOND, VA, April 22, 2025 (GLOBE NEWSWIRE) -- CarMax, Inc. (NYSE: KMX), the nation's largest…
Strategic Integration: Air Charter Advisors expands Flyte’s global reach while advancing revenues within its AI-enabled…
Tustin, CA, April 22, 2025 (GLOBE NEWSWIRE) -- Freeze Tag (OTC: FRZT), a leading creator…
Among Graduates Is Fourth Female Wisconsin Master Cheesemaker® 2025 Wisconsin Master Cheesemakers® The UW-Madison Center…
This website uses cookies.